GLYZIMAC M TABLET

Product Description

GLYZIMAC M TABLET is a powerful oral anti-diabetic combination formulated with Gliclazide 80mg and Metformin 500mga proven dual therapy for effective Type 2 Diabetes Mellitus management. Designed to control blood sugar levels and improve insulin sensitivity, this tablet supports better glycemic control with reduced risk of hypoglycemia.

Manufactured in WHO-GMP certified units, GLYZIMAC M is widely recommended by endocrinologists and diabetologists, making it a high-demand product for pharmaceutical distributors, hospital pharmacies, and bulk medicine suppliers.

Key Benefits:

• Combines insulin secretagogue (Gliclazide) with insulin sensitizer (Metformin)

• Helps manage fasting and postprandial blood glucose levels

• Reduces insulin resistance and enhances beta-cell function

• Promotes stable glycemic control with minimal side effects

Applications:

• First-line or adjunct therapy in Type 2 Diabetes Mellitus

• Recommended in cases requiring dual oral anti-diabetic therapy

• Ideal for long-term diabetes management protocols

Why Choose GLYZIMAC M TABLET?

• Trusted formulation for diabetes care

• Backed by high patient compliance and clinical efficacy

• Attractive trade margins for distributors and retailers

• Ready stock available for bulk supply and PCD distribution